Inventor · disambiguated record
Robin M. Jackman
Also filed as: JACKMAN ROBIN · JACKMAN ROBIN M
15 granted patents·7 pending applications·115 citations·filing 2009–2021
92Inventor score
Top patents by PatentIndex Score
22 records- 0195US8232073B2Quantification of non-reducing end glycan residual compoundsCRAWFORD BRETT E·Filed 2009·Granted Jul 31, 2012·35 cites·15 claims
- 0294US9340822B2Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarkerBIOMARIN PHARM INC·Filed 2014·Granted May 17, 2016·12 cites·23 claims
- 0394US8809009B2Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarkerBIOMARIN PHARM INC·Filed 2012·Granted Aug 19, 2014·14 cites·16 claims
- 0494US8771974B2Methods of determining the presence and/or amount of a biomarker to determine the presence, identity, and/or severity of a lysosomal storage or neurological disorderCRAWFORD BRETT E·Filed 2012·Granted Jul 8, 2014·16 cites·21 claims
- 0592US9915649B2Methods of determining the presence, identity, and/or severity of mucopolysaccharidosis (MPS) VI and IVABIOMARIN PHARM INC·Filed 2016·Granted Mar 13, 2018·4 cites·34 claims
- 0692US9222120B2Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or conditionBIOMARIN PHARM INC·Filed 2014·Granted Dec 29, 2015·13 cites·21 claims
- 0790US9677116B2Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or conditionBIOMARIN PHARM INC·Filed 2015·Granted Jun 13, 2017·4 cites·30 claims
- 0888US10260084B2Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or conditionBIOMARIN PHARM INC·Filed 2017·Granted Apr 16, 2019·2 cites·12 claims
- 0988US9775821B2Compositions for the treatment of autodigestionLEADING BIOSCIENCES INC·Filed 2016·Granted Oct 3, 2017·7 cites·11 claims
- 1088US9314442B2Compositions for the treatment of autodigestionLEADING BIOSCIENCES INC·Filed 2015·Granted Apr 19, 2016·8 cites·3 claims
- 1175US10793894B2Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or conditionBIOMARIN PHARM INC·Filed 2019·Granted Oct 6, 2020·0 cites·20 claims
- 1272US2021025874A1Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarkerBIOMARIN PHARM INC·Filed 2020·Application pending·0 cites
- 1371US2022054439A1Compositions for the treatment of autodigestionLEADING BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1469US10677786B2Methods of diagnosing mucopolysaccharidosis (MPS) I and methods of monitoring treatment of MPS by quantifying a non-reducing end glycan residual compound and comparing to a second biomarkerBIOMARIN PHARM INC·Filed 2018·Granted Jun 9, 2020·0 cites·21 claims
- 1561US11123317B2Compositions for the treatment of autodigestionLEADING BIOSCIENCES INC·Filed 2017·Granted Sep 21, 2021·0 cites·4 claims
- 1658US11306399B2Nanoparticle compositionsJANUARY THERAPEUTICS INC·Filed 2020·Granted Apr 19, 2022·0 cites·18 claims
- 1748US11306111B2Organophosphate derivativesJANUARY THERAPEUTICS INC·Filed 2018·Granted Apr 19, 2022·0 cites·19 claims
- 1843US2023099727A1Nanoparticle compositionsJANUARY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1942US2021299273A1Nanoparticle compositionsJANUARY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2040US2021007999A1Nanoparticle compositionsJANUARY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2134US2021038628A1Nanoparticle compositionsJANUARY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2234US2021008076A1Nanoparticle compositionsJANUARY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robin M. Jackman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →